RecruitingNot ApplicableNCT05061004

Cephea Early Feasibility Study

Sponsor

Abbott Medical Devices

Enrollment

50 participants

Start Date

Apr 28, 2022

Study Type

INTERVENTIONAL

Conditions

Mitral Regurgitation

Summary

The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Cephea Mitral Valve System for people with mitral regurgitation. The study is currently recruiting participants at 22 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECephea Mitral Valve System

Transcatheter mitral valve replacement

Locations(22)

Banner-University Medical Center Phoenix

Phoenix, Arizona, United States

Cedars-Sinai Medical Center

Los Angeles, California, United States

University of California - Davis Medical Center

Sacramento, California, United States

Los Robles Regional Medical Center

Thousand Oaks, California, United States

Emory University Hospital

Atlanta, Georgia, United States

Piedmont Heart Institute

Atlanta, Georgia, United States

Northwestern Memorial Hospital

Chicago, Illinois, United States

Ascension Via Christi Hospitals Wichita

Wichita, Kansas, United States

University of Michigan - Davis Medical Center

Ann Arbor, Michigan, United States

Minneapolis Heart Institute

Minneapolis, Minnesota, United States

New York-Presbyterian/Columbia University Medical Center

New York, New York, United States

Montefiore Medical Center - Moses Campus

The Bronx, New York, United States

Atrium Health - Carolinas Medical Center

Charlotte, North Carolina, United States

The Cleveland Clinic Foundation

Cleveland, Ohio, United States

Allegheny General Hospital - ASRI

Pittsburgh, Pennsylvania, United States

Ascension Saint Thomas

Nashville, Tennessee, United States

Vanderbilt Heart & Vascular Institute

Nashville, Tennessee, United States

Houston Methodist

Houston, Texas, United States

Sentara Norfolk General Hospital

Norfolk, Virginia, United States

Swedish Medical Center

Seattle, Washington, United States

Institut de Cardiologie de Montreal

Montreal, Quebec, Canada

IUCPQ-ULaval

Québec, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05061004

Related Trials

ATLAS (AltaValve) Pivotal Trial

NCT0646574529 locations

The REValve Clinical Trial an Evaluation Of the ReValve Palmetto Valve for the Replacement of the Native Mitral VaLVE

NCT074509113 locations

Capstan Medical TMVR Study: FIH

NCT066001913 locations

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

NCT0549699837 locations

The CardioClip Study

NCT062414301 location